Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Okajima, Eijiro ^a   Yoshikawa, Motokiyo ^a   Masuda, Yasumasa ^a   Shimizu, Kazuhiro ^b   Tanaka, Nobumichi ^c   Hirayama, Akihide ^c   Shimada, Keiji ^c   Fujimoto, Kiyohide ^c   Hirao, Yoshihiko ^c  

^a Nara City Hospital   (Japan)

^b Kashiwai Clinic   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Neoplasms; Prostate; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CYSTOGRAPHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYDRONEPHROSIS; LENGTH OF STAY; LEVATOR ANI MUSCLE; LUNG INFARCTION; LYMPH LEAKAGE; MAJOR CLINICAL STUDY; MORBIDITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME; URETHRA STRICTURE; URINE INCONTINENCE; WIDE EXCISION;

AGED; BIOPSY; DISEASE-FREE SURVIVAL; ENDOSONOGRAPHY; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE;

EID: 84869025739     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-249     Document Type: Article

References (24)

1. Strope SA, Andriole GL. Prostate cancer screening: current status and future perspectives. Nat Rev Urol 2010, 7:487-93. 10.1038/nrurol.2010.120, 20818326.
2. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 2003, 169:157-63. 10.1016/S0022-5347(05)64058-X, 12478126.
3. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002, 167:528-34. 10.1016/S0022-5347(01)69079-7, 11792912.
4. Heidenrich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, European Association of Urology EAU guidelines on prostate cancer. Part I: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011, 59:61-71. 10.1016/j.eururo.2010.10.039, 21056534, European Association of Urology.
5. Scher D, Awindle PW, Scardino PT. National comprehensive cancer network guidelines for the management of prostate cancer. Urology 2003, 61:14-24. 10.1016/S0090-4295(02)02395-6, 12667883.
6. Blute ML, Bostwick DG, Bergstralh EJ, Slezak JM, Martin SK, Amling CL, Zincke H. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 1997, 50:733-739. 10.1016/S0090-4295(97)00450-0, 9372884.
7. Kordan Y, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA, Barocas DA. Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol 2009, 182:2695-2701. 10.1016/j.juro.2009.08.054, 19836759.
8. Fujimoto H. Wide resection of the prostate with neoadjuvant hormone therapy. In the proceeding of the 18th international symposium: Controversies in prostate cancer diagnosis and treatment. Pu YS, Fujimoto H, Kakizoe T, Myers R. Jpn J Clin Oncol 2005, 35:680-689. 10.1093/jjco/hyi180, 16275675.
9. Miyake H, Fujimoto H, Komiyama M, Fujisawa M. Development of " extended radical retropubic prostatectomy" : A surgical technique for improving margin positive rates in prostate cancer. Eur J Surg Oncol 2010, 36:281-286. 10.1016/j.ejso.2009.10.013, 19897336.
10. Fujimoto H. Radical prostatectomy with neoadjuvant hormone therapy for cT3 prostate cancer. Nippon Rinsho 2005, 63:271-278. Article in Japanese.
11. Kawamorita N, Saito S, Ishidoya S, Ito A, Saito H, Kato M, Arai Y. Radical prostatectomy for high-risk prostate cancer: Biochemical outcome. Int J Urol 2009, 16:733-738. 10.1111/j.1442-2042.2009.02352.x, 19674167.
12. Epstein JL. Tumors of the prostate. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. International Agency for Research on Cancer 2004, 179-184. Lyon: World Health Organization Classification of Tumours, John NE.
13. Epstein JL. Tumors of the prostate. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. International Agency for Research on Cancer 2004, 61. Lyon: World Health Organization Classification of Tumours, Ebele JN, Sauter G, Epstein JI, Sesterhenn IA, ISBN 92 83 22415 9.
14. Inagaki T, Kohjimoto Y, Nishizawa, Kuramoto T, Nanpo Y, Fujii R, Matsumura N, Shintani Y, Uekado Y, Hara I. PSA at postoperative three months can predict biochemical recurrence in patients with pathological T3 prostate cancer following radical prostatectomy. Int J Urol 2009, 16:941-946. 10.1111/j.1442-2042.2009.02401.x, 19832922.
15. Naito S, Kuroiwa K, Kinukawa N, Goto K, Koga H, Ogawa O, Murai M, Shiraishi T, Clinicopathological Research Group for Localized Prostate Cancer Investigators Validation of Partin tables and development of a preoperative nomogram for Japanese patients With clinically localized prostate cancer using 2005 International Society of Urological Pathology Consensus on Gleason Grading: Data from the Clinicopathological Research Group for Localized Prostate Cancer. J Urol 2008, 180:904-910. 10.1016/j.juro.2008.05.047, 18635221, Clinicopathological Research Group for Localized Prostate Cancer Investigators.
16. Schiavina R, Bertaccini A, Franceschelli A, Manferrari F, Vagnoni V, Borghesi M, Morselli-Labate AM, Martorana G. The impact of the extent of lymph-node dissection on biochemical relapse after radical prostatectomy in node-negative patients. Anticancer Res 2010, 30:2297-2302.
17. Hisasue S, Takahashi A, Kato R, Shimizu T, Masumori N, Itoh N, Tsukamoto T. Early and late complications of radical retropubic prostatectomy: Experience in a single institution. Jpn J Clin Oncol 2004, 34:274-279. 10.1093/jjco/hyh042, 15231863.
18. Frota R, Turna B, Barros R, Gill IS. Comparison of radical prostatectomy techniques: open, laparoscopic and robotic assisted. Int Braz J Urol 2008, 34:259-269. 10.1590/S1677-55382008000300002, 18601755.
19. Kupelian PA, Katcher J, Levin HS, Klein EA. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Radiation Oncology Biol. Phys 1977, 37:1043-1052.
20. Kordon Y, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA, Barocas DA. Impact of apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol 2009, 182:2695-2701. 10.1016/j.juro.2009.08.054, 19836759.
21. Laven BA, Alsikafi NF, Yang XJ, Brendler CB. Minor modifications in apical dissection of radical retropubic prostatectomy in patients with clinical stage 2 prostate cancer reduce positive surgical margin incidence. Urology 2004, 63:95-98. 10.1016/j.urology.2003.08.037, 14751357.
22. Hernandez DJ, Nielsen ME, Han M, Rock BJ, Partin AW, Walsh PC, Epstein JI. Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy. Urology 2008, 72:172-176. 10.1016/j.urology.2007.10.055, 2603620, 18304619.
23. Preston MA, Carrière M, Raju G, Morash C, Doucette S, Gerridzen RG, Bella AJ, Eastham JA, Scardino PT, Cagiannos I. The prognostic significance of capsular incision into tumor during radical prostatectomy. Eur Urol 2010, 59:613-618.
24. Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011, 185:869-875. 10.1016/j.juro.2010.10.057, 21239008.